Ultrasound-mediated strategies in opening brain barriers for drug brain delivery

Bibliography

• Redzic Z. Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS 2011;8:3
   PubMedGoogle Scholar
• Decleves X, Amiel A, Delattre JY, Scherrmann JM. Role of ABC transporters in the chemoresistance of human gliomas. Curr Cancer Drug Targets 2006;6:433-45
   PubMed Web of Science ®Google Scholar
• Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005;57:173-85
   PubMed Web of Science ®Google Scholar
• Dean M, Hamon Y, Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 2001;42:1007-17
   PubMed Web of Science ®Google Scholar
• MW B, TS R. Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol 1969;40:648-77
   PubMed Web of Science ®Google Scholar
• Saunders NR, Ek CJ, Habgood MD, Dziegielewska KM. Barriers in the brain: a renaissance? Trends Neurosci 2008;31:279-86
   PubMed Web of Science ®Google Scholar
• Saunders NR, Knott GW, Dziegielewska KM. Barriers in the immature brain. Cell Mol Neurobiol 2000;20:29-40
   PubMed Web of Science ®Google Scholar
• Begley DJ, Brightman MW. Structural and functional aspects of the blood-brain barrier. Prog Drug Res 2003;61:39-78
   PubMedGoogle Scholar
• Janigro D. Are you in or out? Leukocyte, ion, and neurotransmitter permeability across the epileptic blood-brain barrier. Epilepsia 2012;53(Suppl 1):26-34
   PubMed Web of Science ®Google Scholar
• Vykhodtseva N, McDannold N, Hynynen K. Progress and problems in the application of focused ultrasound for blood-brain barrier disruption. Ultrasonics 2008;48:279-96
   PubMed Web of Science ®Google Scholar
• Roberts RL, Fine RE, Sandra A. Receptor-mediated endocytosis of transferrin at the blood-brain barrier. J Cell Sci 1993;104(Pt 2):521-32
   PubMedGoogle Scholar
• Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 2001;220:640-6
   PubMed Web of Science ®Google Scholar
• Sai Y, Kajita M, Tamai I, et al. Adsorptive-mediated endocytosis of a basic peptide in enterocyte-like Caco-2 cells. Am J Physiol 1998;275:G514-20
   PubMed Web of Science ®Google Scholar
• Tamai I, Tsuji A. Transporter-mediated permeation of drugs across the blood-brain barrier. J Pharm Sci 2000;89:1371-88
   PubMed Web of Science ®Google Scholar
• Tsuji A. Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems. NeuroRx 2005;2:54-62
   PubMedGoogle Scholar
• Banks WA, Kastin AJ, Ehrensing CA. Endogenous peptide Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport system-1. J Neurosci Res 1993;35:690-5
   PubMed Web of Science ®Google Scholar
• Schinkel AH. The roles of P-glycoprotein and MRP1 in the blood-brain and blood-cerebrospinal fluid barriers. Adv Exp Med Biol 2001;500:365-72
   PubMed Web of Science ®Google Scholar
• Miller G. Drug targeting. Breaking down barriers. Science 2002;297:1116-18
   PubMed Web of Science ®Google Scholar
• Wu J, Nyborg WL. Ultrasound, cavitation bubbles and their interaction with cells. Adv Drug Deliv Rev 2008;60:1103-16
   PubMed Web of Science ®Google Scholar
• Sboros V. Response of contrast agents to ultrasound. Adv Drug Deliv Rev 2008;60:1117-36
   PubMed Web of Science ®Google Scholar
• Leighton TG. What is ultrasound? Prog Biophys Mol Biol 2007;93:3-83
   PubMed Web of Science ®Google Scholar
• Deng CX. Targeted drug delivery across the blood-brain barrier using ultrasound technique. Ther Deliv 2010;1:819-48
   PubMedGoogle Scholar
• Barnard JW, Fry WJ, Fry FJ, Krumins RF. Effects of high intensity ultrasound on the central nervous system of the cat. J Comp Neurol 1955;103:459-84
   PubMed Web of Science ®Google Scholar
• Ballantine HT Jr, Bell E, Manlapaz J. Progress and problems in the neurological applications of focused ultrasound. J Neurosurg 1960;17:858-76
   PubMed Web of Science ®Google Scholar
• Warwick R, Pond J. Trackless lesions in nervous tissues produced by high intensity focused ultrasound (high-frequency mechanical waves). J Anat 1968;102:387-405
   PubMed Web of Science ®Google Scholar
• Patrick JT, Nolting MN, Goss SA, et al. Ultrasound and the blood-brain barrier. Adv Exp Med Biol 1990;267:369-81
   PubMedGoogle Scholar
• Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA. Non-invasive opening of BBB by focused ultrasound. Acta Neurochir Suppl 2003;86:555-8
   PubMedGoogle Scholar
• Reinhard M, Hetzel A, Kruger S, et al. Blood-brain barrier disruption by low-frequency ultrasound. Stroke 2006;37:1546-8
   PubMed Web of Science ®Google Scholar
• Nyborg WL. Biological effects of ultrasound: development of safety guidelines. Part II: general review. Ultrasound Med Biol 2001;27:301-33
   PubMed Web of Science ®Google Scholar
• Deng CX, Xu Q, Apfel RE, Holland CK. In vitro measurements of inertial cavitation thresholds in human blood. Ultrasound Med Biol 1996;22:939-48
   PubMed Web of Science ®Google Scholar
• Shivers RR, Wijsman JA. Blood-brain barrier permeability during hyperthermia. Prog Brain Res 1998;115:413-24
   PubMed Web of Science ®Google Scholar
• Cho CW, Liu Y, Cobb WN, et al. Ultrasound-induced mild hyperthermia as a novel approach to increase drug uptake in brain microvessel endothelial cells. Pharm Res 2002;19:1123-9
   PubMed Web of Science ®Google Scholar
• McDannold N, Vykhodtseva N, Jolesz FA, Hynynen K. MRI investigation of the threshold for thermally induced blood-brain barrier disruption and brain tissue damage in the rabbit brain. Magn Reson Med 2004;51:913-23
   PubMed Web of Science ®Google Scholar
• Ng KY, Cho CW, Henthorn TK, Tanguay RL. Effect of heat preconditioning on the uptake and permeability of R123 in brain microvessel endothelial cells during mild heat treatment. J Pharm Sci 2004;93:896-907
   PubMed Web of Science ®Google Scholar
• Wu J. Shear stress in cells generated by ultrasound. Prog Biophys Mol Biol 2007;93:363-73
   PubMed Web of Science ®Google Scholar
• VanBavel E. Effects of shear stress on endothelial cells: possible relevance for ultrasound applications. Prog Biophys Mol Biol 2007;93:374-83
   PubMed Web of Science ®Google Scholar
• Rooney JA. Hemolysis near an ultrasonically pulsating gas bubble. Science 1970;169:869-71
   PubMed Web of Science ®Google Scholar
• Schlicher RK, Radhakrishna H, Tolentino TP, et al. Mechanism of intracellular delivery by acoustic cavitation. Ultrasound Med Biol 2006;32:915-24
   PubMed Web of Science ®Google Scholar
• Prentice P, Cuschieri A, Dholakia K, et al. Membrane disruption by optically controlled microbubble cavitation. Nat Phys 2005;1:107-10
   Web of Science ®Google Scholar
• Okada K, Kudo N, Hassan MA, et al. Threshold curves obtained under various gaseous conditions for free radical generation by burst ultrasound - effects of dissolved gas, microbubbles and gas transport from the air. Ultrason Sonochem 2009;16:512-18
   PubMed Web of Science ®Google Scholar
• Hallow DM, Mahajan AD, McCutchen TE, Prausnitz MR. Measurement and correlation of acoustic cavitation with cellular bioeffects. Ultrasound Med Biol 2006;32:1111-22
   PubMed Web of Science ®Google Scholar
• van Wamel A, Kooiman K, Harteveld M, et al. Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release 2006;112:149-55
   PubMed Web of Science ®Google Scholar
• Forbes MM, Steinberg RL, O'Brien WD Jr. Examination of inertial cavitation of Optison in producing sonoporation of chinese hamster ovary cells. Ultrasound Med Biol 2008;34:2009-18
   PubMed Web of Science ®Google Scholar
• Apfel RE, Holland CK. Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound. Ultrasound Med Biol 1991;17:179-85
   PubMed Web of Science ®Google Scholar
• Holland CK, Apfel RE. Thresholds for transient cavitation produced by pulsed ultrasound in a controlled nuclei environment. J Acoust Soc Am 1990;88:2059-69
   PubMed Web of Science ®Google Scholar
• Ohl CD, Arora M, Ikink R, et al. Sonoporation from jetting cavitation bubbles. Biophys J 2006;91:4285-95
   PubMed Web of Science ®Google Scholar
• Ferrara K, Pollard R, Borden M. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 2007;9:415-47
   PubMed Web of Science ®Google Scholar
• Ferrara KW. Driving delivery vehicles with ultrasound. Adv Drug Deliv Rev 2008;60:1097-102
   PubMed Web of Science ®Google Scholar
• Price RJ, Skyba DM, Kaul S, Skalak TC. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation 1998;98:1264-7
   PubMed Web of Science ®Google Scholar
• Postema M, van Wamel A, Lancee CT, de Jong N. Ultrasound-induced encapsulated microbubble phenomena. Ultrasound Med Biol 2004;30:827-40
   PubMed Web of Science ®Google Scholar
• Rosenthal I, Sostaric JZ, Riesz P. Sonodynamic therapy–a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 2004;11:349-63
   PubMed Web of Science ®Google Scholar
• Juffermans LJ, Dijkmans PA, Musters RJ, et al. Transient permeabilization of cell membranes by ultrasound-exposed microbubbles is related to formation of hydrogen peroxide. Am J Physiol Heart Circ Physiol 2006;291:H1595-601
   PubMed Web of Science ®Google Scholar
• Mitragotri S. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat Rev Drug Discov 2005;4:255-60
   PubMed Web of Science ®Google Scholar
• Heimburger RF. Ultrasound augmentation of central nervous system tumor therapy. Indiana Med 1985;78:469-76
   PubMedGoogle Scholar
• Guthkelch AN, Carter LP, Cassady JR, et al. Treatment of malignant brain tumors with focused ultrasound hyperthermia and radiation: results of a phase I trial. J Neurooncol 1991;10:271-84
   PubMed Web of Science ®Google Scholar
• Hynynen K, Jolesz FA. Demonstration of potential noninvasive ultrasound brain therapy through an intact skull. Ultrasound Med Biol 1998;24:275-83
   PubMed Web of Science ®Google Scholar
• Sun J, Hynynen K. Focusing of therapeutic ultrasound through a human skull: a numerical study. J Acoust Soc Am 1998;104:1705-15
   PubMed Web of Science ®Google Scholar
• Pernot M, Aubry JF, Tanter M, et al. High power transcranial beam steering for ultrasonic brain therapy. Phys Med Biol 2003;48:2577-89
   PubMed Web of Science ®Google Scholar
• Aubry JF, Tanter M, Pernot M, et al. Experimental demonstration of noninvasive transskull adaptive focusing based on prior computed tomography scans. J Acoust Soc Am 2003;113:84-93
   PubMed Web of Science ®Google Scholar
• Clement GT, Hynynen K. A non-invasive method for focusing ultrasound through the human skull. Phys Med Biol 2002;47:1219-36
   PubMed Web of Science ®Google Scholar
• Yin X, Hynynen K. A numerical study of transcranial focused ultrasound beam propagation at low frequency. Phys Med Biol 2005;50:1821-36
   PubMed Web of Science ®Google Scholar
• Clement GT, White PJ, Hynynen K. Enhanced ultrasound transmission through the human skull using shear mode conversion. J Acoust Soc Am 2004;115:1356-64
   PubMed Web of Science ®Google Scholar
• Hynynen K, Clement GT, McDannold N, et al. 500-element ultrasound phased array system for noninvasive focal surgery of the brain: a preliminary rabbit study with ex vivo human skulls. Magn Reson Med 2004;52:100-7
   PubMed Web of Science ®Google Scholar
• Huang Y, Hynynen K. MR-guided focused ultrasound for brain ablation and blood-brain barrier disruption. Methods Mol Biol 2011;711:579-93
   PubMedGoogle Scholar
• Arvanitis CD, Livingstone MS, Vykhodtseva N, McDannold N. Controlled ultrasound-induced blood-brain barrier disruption using passive acoustic emissions monitoring. PLoS One 2012;7:e45783
   PubMed Web of Science ®Google Scholar
• Vykhodtseva NI, Hynynen K, Damianou C. Histologic effects of high intensity pulsed ultrasound exposure with subharmonic emission in rabbit brain in vivo. Ultrasound Med Biol 1995;21:969-79
   PubMed Web of Science ®Google Scholar
• Mesiwala AH, Farrell L, Wenzel HJ, et al. High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo. Ultrasound Med Biol 2002;28:389-400
   PubMed Web of Science ®Google Scholar
• Zhao YZ, Lu CT, Li XK, et al. Improving the cardio protective effect of aFGF in ischemic myocardium with ultrasound-mediated cavitation of heparin modified microbubbles: preliminary experiment. J Drug Target 2012;20:623-31
   PubMed Web of Science ®Google Scholar
• Hernot S, Klibanov AL. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 2008;60:1153-66
   PubMed Web of Science ®Google Scholar
• Hynynen K, McDannold N, Vykhodtseva N, et al. Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery. J Neurosurg 2006;105:445-54
   PubMed Web of Science ®Google Scholar
• Apfel RE. Acoustic cavitation: a possible consequence of biomedical uses of ultrasound. Br J Cancer Suppl 1982;5:140-6
   PubMedGoogle Scholar
• Crum L, Fowlkes J. Acoustic cavitation generated by microsecond pulses of ultrasound. Nature 1986;319:52-4
   Web of Science ®Google Scholar
• McDannold N, Vykhodtseva N, Hynynen K. Use of ultrasound pulses combined with Definity for targeted blood-brain barrier disruption: a feasibility study. Ultrasound Med Biol 2007;33:584-90
   PubMed Web of Science ®Google Scholar
• McDannold N, Vykhodtseva N, Raymond S, et al. MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits. Ultrasound Med Biol 2005;31:1527-37
   PubMed Web of Science ®Google Scholar
• Treat LH, McDannold N, Vykhodtseva N, et al. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 2007;121:901-7
   PubMed Web of Science ®Google Scholar
• Tung YS, Vlachos F, Feshitan JA, et al. The mechanism of interaction between focused ultrasound and microbubbles in blood-brain barrier opening in mice. J Acoust Soc Am 2011;130:3059-67
   PubMed Web of Science ®Google Scholar
• McDannold N, Vykhodtseva N, Hynynen K. Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity. Phys Med Biol 2006;51:793-807
   PubMed Web of Science ®Google Scholar
• Miller DL. A review of the ultrasonic bioeffects of microsonation, gas-body activation, and related cavitation-like phenomena. Ultrasound Med Biol 1987;13:443-70
   PubMed Web of Science ®Google Scholar
• Krizanac-Bengez L, Mayberg MR, Janigro D. The cerebral vasculature as a therapeutic target for neurological disorders and the role of shear stress in vascular homeostatis and pathophysiology. Neurol Res 2004;26:846-53
   PubMed Web of Science ®Google Scholar
• Flynn H. Generation of transient cavities in liquids by microsecond pulses of ultrasound. J Acoust Soc Am 1982;72:1926-32
   Web of Science ®Google Scholar
• Brujan EA. The role of cavitation microjets in the therapeutic applications of ultrasound. Ultrasound Med Biol 2004;30:381-7
   PubMed Web of Science ®Google Scholar
• Kondo T, Kodaira T, Kano E. Free radical formation induced by ultrasound and its effects on strand breaks in DNA of cultured FM3A cells. Free Radic Res Commun 1993;19(Suppl 1):S193-200
   PubMedGoogle Scholar
• Deng CX, Sieling F, Pan H, Cui J. Ultrasound-induced cell membrane porosity. Ultrasound Med Biol 2004;30:519-26
   PubMed Web of Science ®Google Scholar
• Miller MW, Miller DL, Brayman AA. A review of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective. Ultrasound Med Biol 1996;22:1131-54
   PubMed Web of Science ®Google Scholar
• Hynynen K, McDannold N, Sheikov NA, et al. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 2005;24:12-20
   PubMed Web of Science ®Google Scholar
• Sheikov N, McDannold N, Vykhodtseva N, et al. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med Biol 2004;30:979-89
   PubMed Web of Science ®Google Scholar
• Sassaroli E, Hynynen K. Forced linear oscillations of microbubbles in blood capillaries. J Acoust Soc Am 2004;115:3235-43
   PubMed Web of Science ®Google Scholar
• Xie F, Boska MD, Lof J, et al. Effects of transcranial ultrasound and intravenous microbubbles on blood brain barrier permeability in a large animal model. Ultrasound Med Biol 2008;34:2028-34
   PubMed Web of Science ®Google Scholar
• Sassaroli E, Hynynen K. Cavitation threshold of microbubbles in gel tunnels by focused ultrasound. Ultrasound Med Biol 2007;33:1651-60
   PubMed Web of Science ®Google Scholar
• Tung YS, Choi JJ, Baseri B, Konofagou EE. Identifying the inertial cavitation threshold and skull effects in a vessel phantom using focused ultrasound and microbubbles. Ultrasound Med Biol 2010;36:840-52
   PubMed Web of Science ®Google Scholar
• Kumon RE, Aehle M, Sabens D, et al. Spatiotemporal effects of sonoporation measured by real-time calcium imaging. Ultrasound Med Biol 2009;35:494-506
   PubMed Web of Science ®Google Scholar
• Kumon RE, Aehle M, Sabens D, et al. Ultrasound-induced calcium oscillations and waves in Chinese hamster ovary cells in the presence of microbubbles. Biophys J 2007;93:L29-31
   PubMed Web of Science ®Google Scholar
• Hynynen K, McDannold N, Martin H, et al. The threshold for brain damage in rabbits induced by bursts of ultrasound in the presence of an ultrasound contrast agent (Optison). Ultrasound Med Biol 2003;29:473-81
   PubMed Web of Science ®Google Scholar
• Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol 2000;20:131-47
   PubMed Web of Science ®Google Scholar
• Kinoshita M, McDannold N, Jolesz FA, Hynynen K. Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. Proc Natl Acad Sci USA 2006;103:11719-23
   PubMed Web of Science ®Google Scholar
• Benz CC, O'Hagan RC, Richter B, et al. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene 1997;15:1513-25
   PubMed Web of Science ®Google Scholar
• Bell R. What can we learn from Herceptin trials in metastatic breast cancer? Oncology 2002;63(Suppl 1):39-46
   PubMedGoogle Scholar
• Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001;344:783-92
   PubMed Web of Science ®Google Scholar
• Fenner MH, Possinger K. Chemotherapy for breast cancer brain metastases. Onkologie 2002;25:474-9
   PubMed Web of Science ®Google Scholar
• Bendell JC, Domchek SM, Burstein HJ, et al. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer 2003;97:2972-7
   PubMed Web of Science ®Google Scholar
• Burstein HJ, Lieberman G, Slamon DJ, et al. Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy. Ann Oncol 2005;16:1772-7
   PubMed Web of Science ®Google Scholar
• Lower E, Drosick D, Blau R, et al. Increased rate of brain metastasis with trastuzumab therapy not associated with impaired survival. Clin Breast Cancer 2003;4:114-19
   PubMedGoogle Scholar
• Bristol IJ, Buchholz TA. Inflammatory breast cancer: current concepts in local management. Breast Dis 2005;22:75-83
   PubMedGoogle Scholar
• Ulrich-Pur H, Kornek GV, Haider K, et al. Phase II trial of pegylated liposomal doxorubicin (Caelyx) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer. Acta Oncol 2007;46:208-13
   PubMed Web of Science ®Google Scholar
• Thigpen JT, Aghajanian CA, Alberts DS, et al. Role of pegylated liposomal doxorubicin in ovarian cancer. Gynecol Oncol 2005;96:10-18
   PubMed Web of Science ®Google Scholar
• Recchia F, Saggio G, Amiconi G, et al. A multicenter phase II study of pegylated liposomal doxorubicin and oxaliplatin in recurrent ovarian cancer. Gynecol Oncol 2007;106:164-9
   PubMed Web of Science ®Google Scholar
• Pignata S, Scambia G, Pisano C, et al. A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group. Br J Cancer 2007;96:1639-43
   PubMed Web of Science ®Google Scholar
• Wang X, Pang L, Feng J. A phase II study of etoposide, doxorubicin, and carboplatin in the treatment of advanced gastric cancer. Am J Clin Oncol 2002;25:71-5
   PubMed Web of Science ®Google Scholar
• Ardizzoni A, Tjan-Heijnen VC, Postmus PE, et al. Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923. J Clin Oncol 2002;20:3947-55
   PubMed Web of Science ®Google Scholar
• Gilliam LK, Kohn AD, Lalani T, et al. Capecitabine therapy for refractory metastatic thyroid carcinoma: a case series. Thyroid 2006;16:801-10
   PubMed Web of Science ®Google Scholar
• Palmieri C, Treibel T, Large O, Bower M. AIDS-related non-Hodgkin's lymphoma in the first decade of highly active antiretroviral therapy. QJM 2006;99:811-26
   PubMed Web of Science ®Google Scholar
• Laskar S, Gupta T, Vimal S, et al. Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need? J Clin Oncol 2004;22:62-8
   PubMed Web of Science ®Google Scholar
• Pulini S, Rupoli S, Goteri G, et al. Pegylated liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphomas. Haematologica 2007;92:686-9
   PubMed Web of Science ®Google Scholar
• Hawkins DS, Arndt CA. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy. Cancer 2003;98:2447-56
   PubMed Web of Science ®Google Scholar
• Grobmyer SR, Maki RG, Demetri GD, et al. Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol 2004;15:1667-72
   PubMed Web of Science ®Google Scholar
• Zhao YZ, Dai DD, Lu CT, et al. Using acoustic cavitation to enhance chemotherapy of DOX liposomes: experiment in vitro and in vivo. Drug Dev Ind Pharm 2012;38:1090-8
   PubMed Web of Science ®Google Scholar
• Yang W, Yu XC, Chen XY, et al. Pharmacokinetics and tissue distribution profile of icariin propylene glycol-liposome intraperitoneal injection in mice. J Pharm Pharmacol 2012;64:190-8
   PubMed Web of Science ®Google Scholar
• Ferrara KW, Borden MA, Zhang H. Lipid-shelled vehicles: engineering for ultrasound molecular imaging and drug delivery. Acc Chem Res 2009;42:881-92
   PubMed Web of Science ®Google Scholar
• Cummings J, McArdle CS. Studies on the in vivo disposition of adriamycin in human tumours which exhibit different responses to the drug. Br J Cancer 1986;53:835-8
   PubMed Web of Science ®Google Scholar
• Rapoport NY, Kennedy AM, Shea JE, et al. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J Control Release 2009;138:268-76
   PubMed Web of Science ®Google Scholar
• Du L, Jin Y, Zhou W, Zhao J. Ultrasound-triggered drug release and enhanced anticancer effect of doxorubicin-loaded poly(D,L-lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanodroplets. Ultrasound Med Biol 2011;37:1252-8
   PubMed Web of Science ®Google Scholar
• Rapoport N, Christensen DA, Kennedy AM, Nam KH. Cavitation properties of block copolymer stabilized phase-shift nanoemulsions used as drug carriers. Ultrasound Med Biol 2010;36:419-29
   PubMed Web of Science ®Google Scholar
• Rapoport N, Nam KH, Gupta R, et al. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. J Control Release 2011;153:4-15
   PubMed Web of Science ®Google Scholar
• Sheeran PS, Luois S, Dayton PA, Matsunaga TO. Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound. Langmuir 2011;27:10412-20
   PubMed Web of Science ®Google Scholar
• Liu Z, Lammers T, Ehling J, et al. Iron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imaging. Biomaterials 2011;32:6155-63
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 2011;63:136-51
   PubMed Web of Science ®Google Scholar
• Sheeran PS, Wong VP, Luois S, et al. Decafluorobutane as a phase-change contrast agent for low-energy extravascular ultrasonic imaging. Ultrasound Med Biol 2011;37:1518-30
   PubMed Web of Science ®Google Scholar
• Zhao YZ, Sun CZ, Lu CT, et al. Characterization and anti-tumor activity of chemical conjugation of doxorubicin in polymeric micelles (DOX-P) in vitro. Cancer Lett 2011;311:187-94
   PubMed Web of Science ®Google Scholar
• Husseini GA, Pitt WG. Micelles and nanoparticles for ultrasonic drug and gene delivery. Adv Drug Deliv Rev 2008;60:1137-52
   PubMed Web of Science ®Google Scholar
• Marin A, Sun H, Husseini GA, et al. Drug delivery in pluronic micelles: effect of high-frequency ultrasound on drug release from micelles and intracellular uptake. J Control Release 2002;84:39-47
   PubMed Web of Science ®Google Scholar
• Victorov IV, Prass K, Dirnagl U. Improved selective, simple, and contrast staining of acidophilic neurons with vanadium acid fuchsin. Brain Res Brain Res Protoc 2000;5:135-9
   PubMedGoogle Scholar
• Wang F, Shi Y, Lu L, et al. Targeted delivery of GDNF through the blood-brain barrier by MRI-guided focused ultrasound. PLoS One 2012;7:e52925
   PubMed Web of Science ®Google Scholar
• Zhang L, Xu JS, Sanders VM, et al. Multifunctional microbubbles for image-guided antivascular endothelial growth factor therapy. J Biomed Opt 2010;15:030515
   Google Scholar